Delivery Order SPE2DB20D3101-SPE2DB23FRKP5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,001.80 firm fixed-price delivery order is for the supply of EpiPen 2-Pak 0.3 mg auto-injectors. The contract has a completion date of March 16, 2023 and does not utilize any set-aside designations. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for EpiPen 2-Pak 0.3 mg auto-injectors. The $3,526.52 firm fixed-price contract has a completion date of April 18, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,516.57 contract is for the procurement of EpiPen 2-Pak 0.3 mg auto-injectors to support federal healthcare programs. The contract has an ultimate completion date of August 16, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,614.62, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 16, 2021. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award IDC...
- This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to the U.S. Department of Defense (DoD) and its military healthcare programs. The contract, valued at $2,146.92, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of 4,565,054,879 units of the EpiPen (epinephrine 0.3 mg auto-injector) medical device. The $1,325.11 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,884.27 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This federal contract award for $1,427.51 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of EPIPEN 2-PAK 0.3 MG AUTO-INJCT 2S. This is a delivery order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FM9U1) valued at $4,549.38 for the supply of EpiPen 2-Pak 0.3 mg auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 4, 2023, with an ultimate completion date of April 5, 2023. The contract is a firm fixed-price agreement, and no set-aside designation was used. Amerisourcebergen, a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,935.00, is a delivery order for the supply of EpiPen 2-Pak 0.3 mg auto-injectors. The contract has a completion date of September 14, 2022 and uses a firm fixed-price pricing structure. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRKP5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,551.20 firm fixed-price delivery order is for 4,560,832,376 EpiPen 2-Pak 0.3 mg auto-injectors, with a completion date of May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award reviewed does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/4/23 |